Home
>
National Drug Code (NDC)
>
Carbamazepine
Carbamazepine - 0093-5513-89 - (Carbamazepine)
Drug Information of Carbamazepine
| Product NDC: | 0093-5513 |
| Proprietary Name: | Carbamazepine |
| Non Proprietary Name: | Carbamazepine |
| Active Ingredient(s): | 200 mg/1 & nbsp; Carbamazepine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Carbamazepine
| Product NDC: | 0093-5513 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078592 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130211 |
Package Information of Carbamazepine
| Package NDC: | 0093-5513-89 |
| Package Description: | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-5513-89) |
NDC Information of Carbamazepine
| NDC Code | 0093-5513-89 |
| Proprietary Name | Carbamazepine |
| Package Description | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-5513-89) |
| Product NDC | 0093-5513 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Carbamazepine |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20130211 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | CARBAMAZEPINE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
